Sector Watch: Healthcare - Sep 24 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $119.96 +1.41 1.19% | XBI: $96.62 +1.08 1.13% | Updated Sep 24, 2018 05:14 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| AMRN52WH Amarin $4.1B |
12.40+9.41 162.4 M 48.8x |
315% | ||
| HLS52WH HealthSouth $212.7M |
12.50+4.40 261.1 K 5.2x |
54% | ||
| XON Intrexon $2.6B |
19.07+4.56 19.5 M 21.6x |
31% | ||
| ACRX AcelRx Pharmaceuticals $278.8M |
4.60+0.65 3.7 M 7.3x |
16% | ||
| NVAX Novavax $707.8M |
1.85+0.25 18.3 M 4.4x |
16% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| SPPI Spectrum Pharmaceuticals $1.8B |
16.52-4.84 7.6 M 4.7x |
-23% | ||
| XTNT Xtant Medical Holdings $52.6M |
4.00-0.33 30.9 K |
-8% | ||
| BTX BioTime $309.6M |
2.44-0.19 528.7 K |
-7% | ||
| BLPH Bellerophon Therapeutics $63.6M |
1.10-0.08 921.9 K |
-7% | ||
| DPLO Diplomat Pharmacy $1.4B |
19.12-1.32 1.1 M |
-6% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients | Business Wire [businesswire.com]REDUCE-IT? Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint [globenewswire.com]
Intrexon Announces Advances in Production of Medical Cannabis [prnewswire.com]
BioTime Warrants to Expire on October 1, 2018 | Business Wire [businesswire.com]
Protagonist Therapeutics Reports Granting of Inducement Award [prnewswire.com]
Harpoon Therapeutics Announces Appointments to Board of Directors and Management Team | Business Wire [businesswire.com]
Stroke - Pipeline Review, H2 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Oragenics, Inc. to Present Data from Its Lantibiotics Program at the Boulder Peptide Symposium Monday, September 24, 2018 | Business Wire [businesswire.com]
BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders | Business Wire [businesswire.com]
Xtant Medical Announces Amendments to Credit Facility and Issuance of Warrants NYSE:XTNT [globenewswire.com]
BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders | Business & Finance | manchestertimes.com [businesswire.com]
Oragenics, Inc. to Present Data from Its Lantibiotics Program at the Boulder Peptide Symposium Monday, September 24, 2018 | Business & Finance | manchestertimes.com [businesswire.com]
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intrexon Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Business Wire [businesswire.com]
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Intrexon Corporation ? XON | Business Wire [businesswire.com]
CASI Pharmaceuticals Announces $48.5 Million Private Placement [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
